At the upper end of the IPO price band of ₹61 and considering the latest GMP, Dev Accelerator IPO listing price could be ₹71, a premium of 16.39%. While this signals a healthy listing trend for Dev ...

The diversified anchor book of Dev Accelerator comprises anchor investors, including insurance and NBFC treasuries such as Universal Sompo General Insurance Company Limited, Chattisgarh Investments ...

Drees Homes has gotten the first approval for its proposed plan to demolish a golf course in a suburb east of Cincinnati for an enormous development that would include more than 500 residential units ...

CINCINNATI (Cincinnati Business Courier) - A Greater Cincinnati developer has unveiled plans for a vast development, totaling more than 500 residential units and a grocery store, on the site of a ...

Binance Academy, the educational arm of the world’s largest crypto exchange, and the Cardano Foundation, a Swiss-based non-profit driving Cardano’s ecosystem ...

From leaked credentials to ransomware plans, the dark web is full of early warning signs — if you know where and how to look. Here’s how security leaders can monitor these hidden spaces and act before ...

President Trump owns several prominent golf courses around the world, but one of them remains "under review." The President of the United States has been in office since January. Since taking office, ...

IGNOU is offering eight free courses for interested students on management and commerce. The courses are available on SWAYAM portal. Indira Gandhi National Open University, IGNOU, is offering free ...

WALWORTH, N.Y. – The future of the Blue Heron Golf Course, played by legends like Arnold Palmer and John Daly, could be at risk after being acquired by new owners. News10NBC attended a public hearing ...

TL;DR: Half-Life 3, codenamed "HLX," remains in active development with Valve focusing on gameplay mechanics, vehicle and particle systems, enemy AI, and significant optimization efforts. Recent ...

Catch every big hit, every wicket with Crickit, a one stop destination for Live Scores, Match Stats, Infographics & much more. Explore now!

Johnson & Johnson JNJ announced that it is discontinuing the development of an investigational combination therapy involving Imaavy (nipocalimab) in the rheumatoid arthritis (RA) indication. This ...